What is the recommended linezolid dosage, route, and treatment duration for cellulitis in an adult with normal renal and hepatic function?

Linezolid Dosage for Cellulitis

For adults with normal renal and hepatic function, linezolid 600 mg PO or IV twice daily (every 12 hours) is the recommended dose for cellulitis, with treatment duration of 7-14 days for complicated skin and soft tissue infections or 5-10 days for uncomplicated cases. 1, 2

Dosing Specifics

Standard Adult Dosing

• Dose: 600 mg every 12 hours
• Route: Oral (PO) or intravenous (IV) - both are bioequivalent with 100% oral bioavailability 3
• Can be switched: Start IV and transition to oral when clinically improved 4
• Food: May be taken without regard to meals 3

Treatment Duration by Cellulitis Type

Complicated cellulitis (hospitalized patients with deeper infections, major abscesses, infected ulcers/burns):

• 7-14 days is the standard duration 1, 2
• Individualize based on clinical response 1

Uncomplicated cellulitis (outpatient purulent or nonpurulent):

• 5-10 days is recommended 1, 2
• Extend if infection has not improved within 5 days 5

The IDSA guidelines specifically list linezolid as an A-I level recommendation for hospitalized patients with complicated skin and soft tissue infections including cellulitis 1, 2. For outpatients with purulent cellulitis requiring MRSA coverage, linezolid is an A-II recommendation 1.

Clinical Context

Linezolid is particularly indicated when:

• MRSA coverage is needed (purulent cellulitis, failed beta-lactam therapy, systemic toxicity) 1, 2
• Coverage for both MRSA and streptococci is desired (linezolid alone provides this) 1
• Patient cannot tolerate vancomycin or has vancomycin-resistant organisms

Important Monitoring Considerations

Common pitfall: Prolonged linezolid therapy beyond 2-4 weeks significantly increases risk of hematologic toxicity (thrombocytopenia, anemia) 6, 7. For cellulitis, the 7-14 day duration minimizes this risk, but monitor complete blood counts if treatment extends beyond 2 weeks.

Renal/hepatic impairment: No dose adjustment needed for renal or hepatic impairment 3. However, metabolites accumulate in renal failure, though clinical significance is unclear 3. The parent drug clearance remains unchanged.

Drug interactions: Linezolid is a reversible MAO inhibitor - avoid tyramine-rich foods and use caution with serotonergic/adrenergic agents 3.

Pediatric Dosing (if applicable)

• Children ≥12 years: 600 mg PO/IV every 12 hours 1
• Children <12 years: 10 mg/kg/dose every 8 hours (not to exceed 600 mg/dose) 1